Shuwanuo: Q4 2025 Dental Business Revenue Reaches $343 Million, Up 8.6% Year-on-Year

Image Source: Solventum Fourth Quarter 2025 Financial Results

Revenue of $19.98 Billion, Q4 Organic Growth of 3.5% / Q4 Dental Business Growth of 8.6% / 2026 Guidance for Organic Growth of 2%-3%

DENTALGOODNEWS (Leading Dental Industry Media, DGN) | Solventum announced its fourth quarter and full-year 2025 financial results and provided full-year 2026 guidance on February 26, 2026. The financial report shows that the company achieved net sales of $1.998 billion (approximately RMB 13.669 billion) in the fourth quarter of 2025, a year-over-year decrease of 3.7%. On an organic basis, sales increased by 3.5% year-over-year. Full-year net sales were $8.325 billion (approximately RMB 56.955 billion), a year-over-year increase of 0.9%, with full-year organic growth of 3.3%.

In terms of profitability, fourth quarter GAAP net income was $63 million (approximately RMB 431 million), a year-over-year increase of 110.0%. GAAP diluted earnings per share (EPS) were $0.36 (approximately RMB 2.46), compared to $0.17 (approximately RMB 1.16) in the same period last year. Full-year GAAP net income was $1.556 billion (approximately RMB 10.645 billion), a year-over-year increase of 224.8%. Full-year diluted EPS was $8.88 (approximately RMB 60.75), an increase of 221.7% year-over-year. On an adjusted basis, fourth quarter Adjusted Diluted EPS was $1.57 (approximately RMB 10.74), a year-over-year increase of 11.3%. Full-year Adjusted Diluted EPS was $6.11 (approximately RMB 41.80), a year-over-year decrease of 8.8%.

Image Source: Solventum Fourth Quarter 2025 Financial Results

The Dental Solutions segment generated revenue of $343 million (approximately RMB 2.347 billion) in the fourth quarter, a year-over-year increase of 8.6%. Foreign exchange had a positive impact of 2.8 percentage points. Excluding foreign exchange, growth on a constant currency basis was 5.9%, with organic growth also at 5.9%. For the full year 2025, the Dental Solutions segment achieved sales of $1.349 billion (approximately RMB 9.229 billion), a year-over-year increase of 4.2% compared to 2024. On a constant currency basis, growth was 3.1%, with organic growth of 3.3%.

Image Source: Solventum Fourth Quarter 2025 Financial Results

Furthermore, the Dental Solutions segment's operating profit for the fourth quarter was $84 million (approximately RMB 575 million), with an operating margin of 24.4%, higher than the 23.3% in the same period last year. The company noted in its financial report that the overall organic growth this quarter stemmed from positive performance across all business segments, with the Dental Solutions business being one of the primary drivers. Full-year segment operating profit was $346 million (approximately RMB 2.367 billion), with an operating margin of 25.6%, compared to 27.0% in the prior year. This segment covers orthodontic brackets, clear aligners, restorative bonding materials, and a full lifecycle product portfolio from prevention to restoration, and is one of the company's three core businesses.

Image Source: Solventum Fourth Quarter 2025 Financial Results

Regarding the sales and expense structure, the company's selling, general and administrative (SG&A) expenses for the fourth quarter of 2025 were $759 million (approximately RMB 5.193 billion), a year-over-year decrease of 3.2%. Research and development (R&D) expenses were $175 million (approximately RMB 1.197 billion), a year-over-year decrease of 12.1%. On a full-year basis, SG&A expenses were $3.080 billion (approximately RMB 21.072 billion), a year-over-year increase of 10.7%. R&D expenses were $739 million (approximately RMB 5.056 billion), a year-over-year decrease of 4.6%.

Image Source: Solventum Fourth Quarter 2025 Financial Results

In terms of cash flow, cash flow from operating activities in the fourth quarter was $96 million (approximately RMB 657 million), a year-over-year decrease of 56.2%. Free cash flow was $33 million (approximately RMB 226 million), a year-over-year decrease of 64.1%. Full-year cash flow from operating activities was $369 million (approximately RMB 2.524 billion), a decrease of 68.9% compared to the same period in 2024. Full-year free cash flow was -$10 million (approximately RMB -68 million), compared to $805 million (approximately RMB 5.507 billion) in the prior year.

Looking ahead to 2026, the company expects full-year organic sales growth of 2.0% to 3.0%. Excluding an approximate 100 basis point impact from SKU exits, the organic growth range is 3.0% to 4.0%. Adjusted earnings per share are projected to be between $6.40 and $6.60 (approximately RMB 43.78-45.15). Free cash flow is expected to be approximately $200 million (approximately RMB 1.368 billion).